These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20406590)

  • 1. Aeroallergen sensitization in asthma: genetics, environment, and pathophysiology.
    Long A
    Allergy Asthma Proc; 2010; 31(2):89-95. PubMed ID: 20406590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
    Djukanović R; Wilson SJ; Kraft M; Jarjour NN; Steel M; Chung KF; Bao W; Fowler-Taylor A; Matthews J; Busse WW; Holgate ST; Fahy JV
    Am J Respir Crit Care Med; 2004 Sep; 170(6):583-93. PubMed ID: 15172898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathogenesis of bronchial asthma.
    Buc M; Dzurilla M; Vrlik M; Bucova M
    Arch Immunol Ther Exp (Warsz); 2009; 57(5):331-44. PubMed ID: 19688187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the understanding of allergic asthma.
    Frieri M
    Allergy Asthma Proc; 2007; 28(6):614-9. PubMed ID: 18201423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological intervention with anti-immunoglobulin-E antibody to prevent asthma exacerbations.
    Chanez P
    Eur Respir J; 2001 Aug; 18(2):249-50. PubMed ID: 11529279
    [No Abstract]   [Full Text] [Related]  

  • 6. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
    Kupryś-Lipińska I; Kuna P
    Pneumonol Alergol Pol; 2009; 77(1):43-51. PubMed ID: 19308909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of treatment with anti-IgE antibodies (Omalizumab) in a patient with severe asthma and negative skin-prick test results.
    van den Berge M; Pauw RG; de Monchy JG; van Minnen CA; Postma DS; Kerstjens HA
    Chest; 2011 Jan; 139(1):190-3. PubMed ID: 21208879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab in asthma: an update on recent developments.
    Humbert M; Busse W; Hanania NA; Lowe PJ; Canvin J; Erpenbeck VJ; Holgate S
    J Allergy Clin Immunol Pract; 2014; 2(5):525-36.e1. PubMed ID: 25213045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergens and the airway epithelium response: gateway to allergic sensitization.
    Lambrecht BN; Hammad H
    J Allergy Clin Immunol; 2014 Sep; 134(3):499-507. PubMed ID: 25171864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood asthma as an allergic disease: rationale for the development of future treatment.
    Tang ML; Powell CV
    Eur J Pediatr; 2001 Dec; 160(12):696-704. PubMed ID: 11795676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dermatological implications of omalizumab, an anti-IgE antibody].
    Di Lucca-Chrisment J
    Rev Med Suisse; 2015 Apr; 11(468):779-80, 782-3. PubMed ID: 26021140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative therapies for asthma: anti-IgE -- the future?
    Weinberger M
    Paediatr Respir Rev; 2004; 5 Suppl A():S115-8. PubMed ID: 14980255
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of omalizumab in patients with food allergy.
    Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
    Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disease modification and duration of omalizumab treatment in patients with severe allergic asthma].
    Schreiber J; Kopp MV; Korn S; Taube C; Buhl R
    Pneumologie; 2014 Mar; 68(3):187-92. PubMed ID: 24477463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma.
    Kulus M; Hébert J; Garcia E; Fowler Taylor A; Fernandez Vidaurre C; Blogg M
    Curr Med Res Opin; 2010 Jun; 26(6):1285-93. PubMed ID: 20377320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does anti-IgE therapy help in asthma? Efficacy and controversies.
    Avila PC
    Annu Rev Med; 2007; 58():185-203. PubMed ID: 17059361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies and other biologic agents in the treatment of asthma.
    Long AA
    MAbs; 2009; 1(3):237-46. PubMed ID: 20065638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.